Onconova Therapeutics, Inc.

NasdaqCM:ONTX Stock Report

Market Cap: US$18.2m

Onconova Therapeutics Future Growth

Future criteria checks 1/6

Onconova Therapeutics's earnings are forecast to decline at 17.4% per annum while its annual revenue is expected to grow at 12% per year. EPS is expected to decline by 3.6% per annum.

Key information

-17.4%

Earnings growth rate

-3.6%

EPS growth rate

Pharmaceuticals earnings growth21.4%
Revenue growth rate12.0%
Future return on equityn/a
Analyst coverage

Low

Last updated11 Mar 2024

Recent future growth updates

Recent updates

We're Keeping An Eye On Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Rate

Mar 09
We're Keeping An Eye On Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Rate

Here's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Situation

Apr 22
Here's Why We're Watching Onconova Therapeutics' (NASDAQ:ONTX) Cash Burn Situation

Onconova Therapeutics (NASDAQ:ONTX) Is In A Good Position To Deliver On Growth Plans

Jul 27
Onconova Therapeutics (NASDAQ:ONTX) Is In A Good Position To Deliver On Growth Plans

Will Onconova Therapeutics (NASDAQ:ONTX) Spend Its Cash Wisely?

Mar 21
Will Onconova Therapeutics (NASDAQ:ONTX) Spend Its Cash Wisely?

Companies Like Onconova Therapeutics (NASDAQ:ONTX) Are In A Position To Invest In Growth

Dec 06
Companies Like Onconova Therapeutics (NASDAQ:ONTX) Are In A Position To Invest In Growth

Onconova Therapeutics names Mark Gelder as chief medical officer

Jun 01

Onconova Therapeutics announces $8.7M registered direct offering

Jan 07

Onconova cleared to start Phase 1 trial for cancer therapy

Dec 24

Onconova Therapeutics EPS in-line, misses on revenue

Nov 12

Earnings and Revenue Growth Forecasts

NasdaqCM:ONTX - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20260N/AN/AN/A1
12/31/20250-29N/AN/A1
12/31/20240-24N/AN/A2
12/31/20230-21N/AN/A3
9/30/20230-20-17-17N/A
6/30/20230-21-17-17N/A
3/31/20230-21-17-17N/A
12/31/20220-19-16-16N/A
9/30/20220-17-17-17N/A
6/30/20220-15-17-17N/A
3/31/20220-16-17-17N/A
12/31/20210-16-19-19N/A
9/30/20210-19-21-21N/A
6/30/20210-22-22-22N/A
3/31/20210-25-23-23N/A
12/31/20200-25-23-23N/A
9/30/20200-24-23-23N/A
6/30/20200-23-21-21N/A
3/31/20202-19-21-21N/A
12/31/20192-22-21-21N/A
9/30/20192-21-21-21N/A
6/30/20192-22-24-24N/A
3/31/20191-23-24-24N/A
12/31/20181-21-23-23N/A
9/30/20181-21-22-22N/A
6/30/20181-23-22-22N/A
3/31/20181-21-23-23N/A
12/31/20171-24-24-24N/A
9/30/20171-23-24-24N/A
6/30/20172-18N/A-19N/A
3/31/20174-21N/A-17N/A
12/31/20166-20N/A-16N/A
9/30/201615-11N/A-16N/A
6/30/201615-15N/A-22N/A
3/31/201613-19N/A-26N/A
12/31/201511-24N/A-31N/A
9/30/20152-41N/A-40N/A
6/30/20150-50N/A-46N/A
3/31/20150-57N/A-51N/A
12/31/20141-64N/A-58N/A
9/30/20143-65N/A-61N/A
6/30/20144-71N/A-62N/A
3/31/20144-68N/A-64N/A
12/31/20135-65N/A-61N/A
9/30/20136-62N/A-72N/A
6/30/201347-43N/A-16N/A
3/31/201347-38N/A-6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: ONTX is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: ONTX is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: ONTX is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: ONTX's revenue (12% per year) is forecast to grow faster than the US market (8.2% per year).

High Growth Revenue: ONTX's revenue (12% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if ONTX's Return on Equity is forecast to be high in 3 years time


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.